Results: 10
Thromboembolism and Janus Kinase Inhibitors.
- Published in:
- Drug Safety, 2020, v. 43, n. 9, p. 831, doi. 10.1007/s40264-020-00973-w
- By:
- Publication type:
- Article
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward.
- Published in:
- Drug Safety, 2020, v. 43, n. 9, p. 853, doi. 10.1007/s40264-020-00949-w
- By:
- Publication type:
- Article
Pathophysiology of Drug-Induced Hypomagnesaemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Information Visualization Platform for Postmarket Surveillance Decision Support.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.
- Published in:
- 2020
- By:
- Publication type:
- journal article